Company / Book Value per Share
TScan Therapeutics, Inc. Book Value per Share History
FY2021-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Book Value per Share
$2.152
FY2025
5-year range
-$46.355 / $13.786
FY2021-FY2025
Trend
-6.4%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Book Value per Share has declined for 3 consecutive years, from $13.786 in FY2022 to $2.152 in FY2025.
Based on SEC 10-K filings.
$2.152 in FY2025 with a 3-year CAGR of -46.2%.
Declined from $4.135 to $2.152 over the past 2 years.
Book Value per Share over time
Growth rates
- 3-Year CAGR
- -46.2%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- TScan Therapeutics, Inc.'s book value per share has declined for 3 consecutive years.
- 3-year CAGR of -46.2%, indicating a declining trend.
- In FY2025, book value per share decreased 6.4% year-over-year.
- Peak book value per share was recorded in FY2022.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -9.69 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Book Value per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $2.152 | -6.4% |
| FY2024 | $2.3 | -44.4% |
| FY2023 | $4.135 | -70.0% |
| FY2022 | $13.786 | +129.7% |
| FY2021 | -$46.355 | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026